Experience

Davis Polk advised ADC Therapeutics SA on its SEC-registered initial public offering of 14,082,475 common shares, which included the exercise in full by the underwriters of their option to…

Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering by Xilinx, Inc. of $750 million aggregate principal amount of its 2.375%…

Davis Polk advised the joint book-running managers on an SEC-registered offering by General Motors Financial Company, Inc. of its $1.5 billion aggregate principal amount of 5.200% senior…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with an SEC-registered offering by Aon Corporation of $1 billion aggregate principal…

Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering by Uber Technologies, Inc. of $900 million aggregate principal amount of…

Davis Polk advised the joint book-running managers on an SEC-registered offering by Mohawk Industries, Inc. of senior notes due 2030. Mohawk Industries is a global flooring manufacturer…

Davis Polk advised the representatives of the several underwriters on an SEC-registered offering by Anthem, Inc. of $2.5 billion in aggregate principal amount of senior notes, consisting of…

Davis Polk advised the joint book-running managers in connection with a registered offering by Eli Lilly and Company of $1.0 billion aggregate principal amount of its 2.250% notes due 2050…

Davis Polk advised the joint book-running managers and representatives of the underwriters on a registered public offering by Canadian National Railway Company (“CN”) of $600 million…

Davis Polk advised the dealer manager in connection with the private offer by Envision Healthcare Corporation to exchange approximately $106 million of its new first-lien senior secured…